Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.

Müller AM, Jun E, Conlon H, Sadiq SA.

BMC Neurosci. 2012 Mar 21;13:30. doi: 10.1186/1471-2202-13-30.

2.

Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.

Zhang X, Reddy J, Ochi H, Frenkel D, Kuchroo VK, Weiner HL.

Int Immunol. 2006 Apr;18(4):495-503. Epub 2006 Mar 15.

PMID:
16540527
3.

LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells.

Duplan V, Beriou G, Heslan JM, Bruand C, Dutartre P, Mars LT, Liblau RS, Cuturi MC, Saoudi A.

J Immunol. 2006 Jan 15;176(2):839-47.

4.

Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.

Oh K, Park HB, Seo MW, Byoun OJ, Lee DS.

Clin Immunol. 2012 Nov;145(2):122-32. doi: 10.1016/j.clim.2012.08.009. Epub 2012 Aug 23.

PMID:
23001131
6.
7.

IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.

Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL.

Int Immunol. 2004 Feb;16(2):249-56.

PMID:
14734610
8.

Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.

Yuan R, Maeda Y, Li W, Lu W, Cook S, Dowling P.

PLoS One. 2008 Apr 2;3(4):e1924. doi: 10.1371/journal.pone.0001924.

9.

Transplanting of mesenchymal stem cells may affect proliferation and function of CD4(+)T cells in experimental autoimmune encephalomyelitis.

Zhu J, Zhang J, Li Q, Du Y, Qiao B, Hu X.

Exp Clin Transplant. 2012 Oct;10(5):492-500. doi: 10.6002/ect.2011.0197. Epub 2012 Jul 20.

11.

Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses.

MacMillan CJ, Furlong SJ, Doucette CD, Chen PL, Hoskin DW, Easton AS.

J Neuropathol Exp Neurol. 2012 Nov;71(11):983-99. doi: 10.1097/NEN.0b013e3182724831.

PMID:
23037326
13.

Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10.

Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC.

Int Immunol. 1999 Oct;11(10):1625-34.

PMID:
10508180
14.

Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats.

Cautain B, Damoiseaux J, Bernard I, van Straaten H, van Breda Vriesman P, Boneu B, Druet P, Saoudi A.

Eur J Immunol. 2001 Apr;31(4):1132-40.

PMID:
11298338
15.

Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.

Castro SB, Junior CO, Alves CC, Dias AT, Alves LL, Mazzoccoli L, Mesquita FP, Figueiredo NS, Juliano MA, Castañon MC, Gameiro J, Almeida MV, Teixeira HC, Ferreira AP.

Int Immunopharmacol. 2012 Feb;12(2):465-70. doi: 10.1016/j.intimp.2011.12.025. Epub 2012 Jan 13.

16.

Differential regulation of CD4(+) T helper cell responses by curcumin in experimental autoimmune encephalomyelitis.

Kanakasabai S, Casalini E, Walline CC, Mo C, Chearwae W, Bright JJ.

J Nutr Biochem. 2012 Nov;23(11):1498-507. doi: 10.1016/j.jnutbio.2011.10.002. Epub 2012 Mar 7.

PMID:
22402368
17.

Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.

Szczepanik M, Tutaj M, Bryniarski K, Dittel BN.

J Neuroimmunol. 2005 Jul;164(1-2):105-14.

PMID:
15899524
18.

Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-beta/Smads signaling pathways.

Luo BL, Niu RC, Feng JT, Hu CP, Xie XY, Ma LJ.

Arch Med Res. 2008 May;39(4):388-96. doi: 10.1016/j.arcmed.2008.02.002.

PMID:
18375249

Supplemental Content

Support Center